Judith Feinberg, MD

Dr. Feinberg serves as co-chair of the Comorbidities Scientific Interest Group (SIG), which is the former HIV SIG that has expended to include other infections associated with drug use—especially injection drug use—and the other medical complications including overdose and mental health. She also serves on the CTN Steering Committee, the CTN Rural SIG and the Stimulants Task Force.

As an infectious diseases specialist, Dr. Feinberg’s research focused on HIV/AIDS and its complications for several decades before becoming specifically involved in the infections associated with injection drug use and preventing opioid overdose. She developed Ohio’s third syringe exchange—and its first true syringe services program— in southwest Ohio in 2014 after a 9 year effort. Her research focuses on the intersection of substance use and infectious diseases, particularly hepatitis B and C, HIV and infective endocarditis (heart valve infection). In addition to many studies aimed at treating and preventing HIV and the complications of AIDS, Dr. Feinberg has conducted numerous observational and treatment studies connected to substance use, including research on curing hepatitis C in people who are actively injecting drugs, the transmission of hepatitis C from mother to baby, and establishing an effective overdose education and naloxone distribution effort as part of a mobile syringe services program.

Faculty Profile